EN PL
 
EN PL
Current issue
Archive
Online first
About the Journal
Instructions for authors
Books and Events
1/2017 vol. 55
Get citation
EDITORIAL ARTICLE
“To be or not to be” for PET in rheumatology. A marriage of love or of convenience?
Leszek Królicki
 
 
 
More details
Hide details
 
Online publication date: 2017-03-22
 
 
Reumatologia 2017;55(1):9-11
DOI: https://doi.org/10.5114/reum.2017.66679
 
 
Article (PDF)
References (15)
 
REFERENCES (15)
1.
Matsui T, Nakata N, Nagai S, et al. Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis. J Nucl Med 2009; 50: 920-926.
Google Scholar
 
 
2.
Beckers C, Ribbens C, André B, et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med 2004; 45: 956-964.
Google Scholar
 
 
3.
Brown AK, Conaghan PG, Karim Z, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008; 58: 2958-2967.
Google Scholar
 
 
4.
Yamashita H, Kubota K, Mimori A. Clinical value of whole-body PET/CT in patients with active rheumatic diseases 2014. Arthritis Res Ther 2014; 16: 423.
Google Scholar
 
 
5.
Elzinga EH, van der Laken CJ, Comans EF, et al. 18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study. J Nucl Med 2011; 52: 77-80.
Google Scholar
 
 
6.
Kiss E, Kovacs L, Szodoray P. Malignancies in systemic lupus erythematosus. Autoimmun Rev 2010; 9: 195-199.
Google Scholar
 
 
7.
O’Byrne KJ, Dalgleish AG. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 2001; 85: 473-483.
Google Scholar
 
 
8.
Sela O, Shoenfeld Y. Cancer in autoimmune diseases. Semin Arthritis Rheum 1988; 18: 77-87.
Google Scholar
 
 
9.
Carter PH, Zhao Q. Clinically validated approaches to the treatment of autoimmune diseases. Expert Opin Investig Drugs 2010; 19: 195-213.
Google Scholar
 
 
10.
Oh JR, Song HC, Kang SR, et al. The clinical usefulness of 18F-FDG PET/CT in patients with systemic autoimmune disease. Nucl Med Mol Imaging 2011; 45: 177-184.
Google Scholar
 
 
11.
Ergül N, Çermik TF. FDG-PET or PET/CT in fever of unknown origin: the diagnostic role of underlying primary disease. Int J Mol Imaging 2011; 2011: 318051.
Google Scholar
 
 
12.
Balink H, Bennink RJ, van Eck-Smit BL, Verberne HJ. The role of 18F-FDG PET/CT in large-vessel vasculitis: appropriateness of current classification criteria? Biomed Res Int 2014; 2014: 687608.
Google Scholar
 
 
13.
Roivainen A, Parkkola R, Yli-Kerttula T, et al. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis Rheum 2003; 48: 3077-3084.
Google Scholar
 
 
14.
van der Laken CJ, Elzinga EH, Kropholler MA, et al. Noninvasive imaging of macrophages in rheumatoid synovitis using 11C-(R)PK11195 and positron emission tomography. Arthritis Rheum 2008; 58: 3350-3355.
Google Scholar
 
 
15.
Zeman MN, Scott PJ. Current imaging strategies in rheumatoid arthritis. Am J Nucl Med Mol Imaging 2012; 2: 174-220.
Google Scholar
 
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
Send by email
Indexes
 
Keywords index
Topics index
Authors index
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
© 2006-2024 Journal hosting platform by Bentus
Scroll to top